Twin Peaks Wealth Advisors’s Amgen AMGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
Sell
-509
Closed -$179K 316
2026
Q1
$179K Buy
+509
New +$181K 0.05% 200
2025
Q3
Sell
-365
Closed -$104K 255
2025
Q2
$104K Buy
+365
New +$103K 0.03% 231

Other funds holding AMGN

Twin Peaks Wealth Advisors's AMGN Position: Q2 2026 in Review

Twin Peaks Wealth Advisors sold out of Amgen (AMGN) in Q2 2026, closing a stake of 509 shares — an estimated $179K sold.

Twin Peaks Wealth Advisors first reported a position in AMGN in Q2 2025 and held it in 2 quarters. The position peaked at $179K in Q1 2026. 3,158 funds tracked by Wall St. Rank hold AMGN as of Q2 2026.

  • Twin Peaks Wealth Advisors reported no remaining Amgen position as of Q2 2026 after selling out during the quarter.
  • Twin Peaks Wealth Advisors sold 509 Amgen shares in Q2 2026, an estimated $179K.
  • Twin Peaks Wealth Advisors first reported a position in Amgen in Q2 2025 and held it in 2 quarters.
  • Twin Peaks Wealth Advisors's Amgen position peaked at $179K in Q1 2026.
  • 3,158 funds tracked by Wall St. Rank held Amgen as of Q2 2026.

Based on Twin Peaks Wealth Advisors's 13F filing for Q2 2026, filed 13 Aug 2026.